Demyelinating Diseases

  • K. K. Koeller
  • R. G. Ramsey


The spectrum of white matter diseases is broad, with conditions ranging from the relatively benign to the progressively debilitating to the rapidly fulminant and fatal. While a specific diagnosis based on the imaging appearance alone is often not possible because of considerable overlap among the diseases, magnetic resonance imaging (MRI) remains ideal for the detection of many of these diseases because of its sensitivity in identifying free water within the normally myelinated white matter.


Multiple Sclerosis White Matter Progressive Multifocal Leukoencephalopathy Optic Neuritis Acquire Immune Deficiency Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hauser SL (1994) Multiple sclerosis and other demyelinating disease. In: Isselbacher KJ, Graunwald E, Wilson JD, Martin JD, Fauci AS, Kasper DL (eds) Harrison’s principle of internal medicine. McGraw-Hill, New York, pp 2287–2295Google Scholar
  2. 2.
    Farlow MR, Bonine JM (1993) Clinical and neuropathological features of multiple sclerosis. Neuroradiol Clin N Am 3:213–228Google Scholar
  3. 3.
    Trobe JD (1994) High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial. Arch Ophthalmol 112:35–36PubMedCrossRefGoogle Scholar
  4. 4.
    McDonald WI, Compston A, Edan G, Goodkin D, Hartung H-P, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121–127PubMedCrossRefGoogle Scholar
  5. 5.
    Grossman RI, McGowan JC (1998) Perspective of multiple sclerosis. AJNR Am J Neuroradiol 19:1251–1265PubMedGoogle Scholar
  6. 6.
    Niebler G, Harris T, Davis T, Roos K (1992) Fulminant multiple sclerosis. AJNR Am J Neuroradiol 13:1547–1551PubMedGoogle Scholar
  7. 7.
    Gharagozloo AM, Poe LB, Collins GH (1994) Antemortem diagnosis of Balo concentric sclerosis: correlative MR imaging and pathologic features. Radiology 191:817–819PubMedGoogle Scholar
  8. 8.
    Barkhof F, Scheltens P, Frequin STFM, Nauta JJP, Tas MW, Valk J et al (1992) Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs. clinical findings in determining disease activity. AJR Am J Roentgenol 159:1041–1047PubMedGoogle Scholar
  9. 9.
    Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M (1991) Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180:467–474PubMedGoogle Scholar
  10. 10.
    Horowitz AL, Kaplan RD, Grewe G, White RT, Salberg LM (1989) The ovoid lesion: a new MR observation in patients with multiple sclerosis. AJNR Am J Neuroradiol 10:303–305PubMedGoogle Scholar
  11. 11.
    Gean-Marton AD, Vezina LG, Marton KI, Stimac GK, Peyster RG, Taveras JM et al (1991) Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 180:215–221PubMedGoogle Scholar
  12. 12.
    Hashemi RH, Bradley WG Jr, Chen DY, Jordan JE, Queralt JA, Cheng AE et al (1995) Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Radiology 196:505–510PubMedGoogle Scholar
  13. 13.
    Dagher AP, Smirniotopoulous JG (1996) Tumefactive demyelinating lesions. Neuroradiology 38:560–565PubMedCrossRefGoogle Scholar
  14. 14.
    Grossman RI, Gonzalez-Scarano F, Atlas SW, Galetta S, Silberberg DH (1986) Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 161:721–725PubMedGoogle Scholar
  15. 15.
    Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M et al (2000) Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 214:665–670PubMedGoogle Scholar
  16. 16.
    Dietemann JL, Beigelman C, Rumbach L, Vogue M, Tajahmady T, Faubert C et al (1988) Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data. Neuroradiology 30:478–480PubMedCrossRefGoogle Scholar
  17. 17.
    Mehta RC, Pike GB, Enzmann DR (1996) Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. AJNR Am J Neuroradiol 17:1051–1055PubMedGoogle Scholar
  18. 18.
    Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA (1992) MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 13:1535–1543PubMedGoogle Scholar
  19. 19.
    Falini A, Calabrese G, Filippi M, Origgi D, Lipari S, Colombo B et al (1998) Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. AJNR Am J Neuroradiol 19:223–229PubMedGoogle Scholar
  20. 20.
    Singh S, Alexander M, Korah IP (1999) Acute disseminated encephalomyelitis: MR imaging features. AJR Am J Roentgenol 173:1101–1107PubMedGoogle Scholar
  21. 21.
    Whiteman M, Post MJD, Berger JR, Tate LG, Bell MD, Limonte LP (1993) Progressive multifocal leukoencephalopathy in 47 HlV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187:233–240PubMedGoogle Scholar
  22. 22.
    McArthur JC, Sacktor N, Seines O (1999) Human immunodeficiency virus-associated dementia. Semin Neurol 19:105–111CrossRefGoogle Scholar
  23. 23.
    Izquierdo G, Quesada MA, Chacon J, Martel J (1992) Neuroradiologic abnormalities in Marchiafava-Bignami disease of benign evolution. Eur J Radiol 15:71–74PubMedCrossRefGoogle Scholar
  24. 24.
    Miller GM, Baker HL, Okazaki H, Whisnant JP (1988) Central pontine myelinolysis and its imitators: MR findings. Radiology 168:795–802PubMedGoogle Scholar
  25. 25.
    Valk PE, Dillon WP (1991) Radiation injury of the brain. AJNR Am J Neuroradiol 12:45–62PubMedGoogle Scholar
  26. 26.
    Chan Y, Leung S, King AD, Choi PH, Metreweli C (1999) Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. Radiology 213:800–807PubMedGoogle Scholar
  27. 27.
    Davis P, Hoffman JJ, Pearl G, Braun I (1986) CT evaluation of effects of cranial radiation therapy in children. AJR Am J Roentgenol 147:587–592PubMedGoogle Scholar
  28. 28.
    Post JD, Beauchamp NJ (1998) Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 18:353–367Google Scholar
  29. 29.
    Yousry TA, Seelos K, Mayer M, Bruning R, Uttner I, Dichgans M et al (1999) Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). AJNR Am J Neuroradiol 20:91–100PubMedGoogle Scholar
  30. 30.
    Kendall BE (1992) Disorders of lysosomes, peroxisomes, and mitochondria. AJNR Am J Neuroradiol 13:621–653PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • K. K. Koeller
    • 1
  • R. G. Ramsey
    • 2
  1. 1.Department of Radiologic PathologyArmed Forces Institute of PathologyWashington, DCUSA
  2. 2.Premier Health ImagingChicagoUSA

Personalised recommendations